Jennifer Cash

574 total citations
15 papers, 320 citations indexed

About

Jennifer Cash is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Radiation. According to data from OpenAlex, Jennifer Cash has authored 15 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 5 papers in Surgery and 4 papers in Radiation. Recurrent topics in Jennifer Cash's work include Prostate Cancer Treatment and Research (12 papers), Prostate Cancer Diagnosis and Treatment (11 papers) and Advanced Radiotherapy Techniques (4 papers). Jennifer Cash is often cited by papers focused on Prostate Cancer Treatment and Research (12 papers), Prostate Cancer Diagnosis and Treatment (11 papers) and Advanced Radiotherapy Techniques (4 papers). Jennifer Cash collaborates with scholars based in United States. Jennifer Cash's co-authors include Kent E. Wallner, Michael Dattoli, Richard Sorace, Lawrence D. True, James C. Etheridge, Michael Binder, David G. Bostwick, Michael Binder, Jacquelyn A. Gorman and Gail Fraizer and has published in prestigious journals such as Cancer, International Journal of Radiation Oncology*Biology*Physics and Urology.

In The Last Decade

Jennifer Cash

14 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jennifer Cash United States 8 282 163 32 32 28 15 320
Lennart Åström Sweden 9 247 0.9× 119 0.7× 20 0.6× 18 0.6× 15 0.5× 20 294
CLINTON T. HOLLADAY United States 7 448 1.6× 204 1.3× 51 1.6× 73 2.3× 21 0.8× 13 466
Yasir Alayed Canada 10 246 0.9× 182 1.1× 23 0.7× 22 0.7× 11 0.4× 22 297
Mack Roach United States 8 368 1.3× 254 1.6× 41 1.3× 43 1.3× 16 0.6× 8 411
Jochem van der Voort van Zijp Netherlands 5 359 1.3× 208 1.3× 29 0.9× 39 1.2× 14 0.5× 6 406
Kristina Commisso Canada 10 285 1.0× 191 1.2× 26 0.8× 19 0.6× 8 0.3× 13 352
John Dombrowski United States 6 249 0.9× 191 1.2× 46 1.4× 9 0.3× 12 0.4× 11 302
P. Graff-Cailleaud France 6 186 0.7× 62 0.4× 60 1.9× 27 0.8× 14 0.5× 14 224
Susan Cooley United States 5 435 1.5× 372 2.3× 40 1.3× 20 0.6× 9 0.3× 6 476
Joy S. Kim United States 12 332 1.2× 188 1.2× 54 1.7× 19 0.6× 35 1.3× 15 472

Countries citing papers authored by Jennifer Cash

Since Specialization
Citations

This map shows the geographic impact of Jennifer Cash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Cash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Cash more than expected).

Fields of papers citing papers by Jennifer Cash

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Cash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Cash. The network helps show where Jennifer Cash may publish in the future.

Co-authorship network of co-authors of Jennifer Cash

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Cash. A scholar is included among the top collaborators of Jennifer Cash based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Cash. Jennifer Cash is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Dattoli, Michael, Kent E. Wallner, Lawrence D. True, et al.. (2010). Long-Term Outcomes for Patients with Prostate Cancer Having Intermediate and High-Risk Disease, Treated with Combination External Beam Irradiation and Brachytherapy. Journal of Oncology. 2010. 1–6. 24 indexed citations
3.
Cash, Jennifer, et al.. (2007). VEGF transcription and mRNA stability are altered by WT1 not DDS(R384W) expression in LNCaP cells. Oncology Reports. 17(6). 1413–9. 7 indexed citations
4.
Dattoli, Michael, Kent E. Wallner, Lawrence D. True, Jennifer Cash, & Richard Sorace. (2007). Long‐term outcomes after treatment with brachytherapy and supplemental conformal radiation for prostate cancer patients having intermediate and high‐risk features. Cancer. 110(3). 551–555. 45 indexed citations
5.
Dattoli, Michael, Kent E. Wallner, Lawrence D. True, Jennifer Cash, & Richard Sorace. (2007). Long-Term Prostate Cancer Control Using Palladium-103 Brachytherapy and External Beam Radiotherapy in Patients with a High Likelihood of Extracapsular Cancer Extension. Urology. 69(2). 334–337. 8 indexed citations
6.
Fang, Lekun, Michael Dattoli, Kent E. Wallner, et al.. (2007). Prostatic acid phosphatase predicts cancer-specific survival after Palladium-103 brachytherapy for prostate cancer. Brachytherapy. 6(2). 79–80. 2 indexed citations
7.
Cash, Jennifer. (2006). Changing Paradigms: Intensity Modulated Radiation Therapy. Seminars in Oncology Nursing. 22(4). 242–248. 5 indexed citations
8.
Cash, Jennifer. (2006). Power against prostate cancer. Intensity-modulated radiation therapy and interstitial brachytherapy.. PubMed. 14(9). 37–42. 3 indexed citations
9.
Dattoli, Michael, Kent E. Wallner, Lawrence D. True, Jennifer Cash, & Richard Sorace. (2005). Long-term Prostate Cancer Control (13 Year Actuarial) in Patients with a High Likelihood of Extracapsular Cancer Extension Using PD-103 Brachytherapy and Supplemental Beam Radiation. International Journal of Radiation Oncology*Biology*Physics. 63. S298–S298. 1 indexed citations
10.
Dattoli, Michael, Kent E. Wallner, Lawrence D. True, Jennifer Cash, & Richard Sorace. (2003). Long‐term outcomes after treatment with external beam radiation therapy and palladium 103 for patients with higher risk prostate carcinoma. Cancer. 97(4). 979–983. 38 indexed citations
11.
Dattoli, Michael, Richard Sorace, Jennifer Cash, & Kent E. Wallner. (2002). Biochemical failure rates following combination external beam radiation and Palladium-103 boost for clinically localized high risk prostate cancer: 10 year results. International Journal of Radiation Oncology*Biology*Physics. 54(2). 38–38. 2 indexed citations
12.
Dattoli, Michael, Kent E. Wallner, Lawrence D. True, et al.. (1999). Prognostic role of serum prostatic acid phosphatase for 103Pd-based radiation for prostatic carcinoma. International Journal of Radiation Oncology*Biology*Physics. 45(4). 853–856. 42 indexed citations
13.
Dattoli, Michael, Kent E. Wallner, Richard Sorace, et al.. (1996). 103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma. International Journal of Radiation Oncology*Biology*Physics. 35(5). 875–879. 129 indexed citations
14.
Dattoli, Michael, et al.. (1995). 1056 Conformal brachytherapy boost to external beam irradiation for clinically localized high risk prostate cancer. International Journal of Radiation Oncology*Biology*Physics. 32. 251–251. 12 indexed citations
15.
Dattoli, Michael, et al.. (1994). Prostatic brachytherapy using palladium-103 for localized prostate cancer: A report of PSA response and toxicity. International Journal of Radiation Oncology*Biology*Physics. 30. 256–257. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026